Abstract
Activated protein C (APC) is a systemic anti-coagulant and anti-inflammatory factor1,2,3. It reduces organ damage in animal models of sepsis, ischemic injury and stroke1,4,5 and substantially reduces mortality in patients with severe sepsis6. It was not known whether APC acts as a direct cell survival factor or whether its neuroprotective effect5,7 is secondary to its anti-coagulant and anti-inflammatory effects1,2,3. We report that APC directly prevents apoptosis in hypoxic human brain endothelium through transcriptionally dependent inhibition of tumor suppressor protein p53, normalization of the pro-apoptotic Bax/Bcl-2 ratio and reduction of caspase-3 signaling. These mechanisms are distinct from those involving upregulation of the genes encoding the anti-apoptotic Bcl-2 homolog A1 and inhibitor of apoptosis protein-1 (IAP-1) by APC in umbilical vein endothelial cells8,9. Cytoprotection of brain endothelium by APC in vitro required endothelial protein C receptor (EPCR) and protease-activated receptor-1 (PAR-1), as did its in vivo neuroprotective activity in a stroke model of mice with a severe deficiency of EPCR10. This is consistent with work showing the direct effects of APC on cultured cells via EPCR and PAR-1 (ref. 9). Moreover, the in vivo neuroprotective effects of low-dose mouse APC seemed to be independent of its anti-coagulant activity. Thus, APC protects the brain from ischemic injury by acting directly on brain cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Griffin, J.H., Zlokovic, B. & Fernandez, J.A. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin. Hematol. 39, 197–205 (2002).
Griffin, J.H. Blood coagulation. The thrombin paradox. Nature 378, 337–338 (1995).
Esmon, C.T. et al. Endothelial protein C receptor. Thromb. Haemost. 82, 251–258 (1999).
Mizutani, A., Okajima, K., Uchiba, M. & Noguchi, T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95, 3781–3787 (2000).
Shibata, M. et al. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103, 1799–1805 (2001).
Bernard, G.R. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344, 699–709 (2001).
Folsom, A.R. et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100, 736–742 (1999).
Joyce, D.E. et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 276, 11199–11203 (2001).
Riewald, M. et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880–1882 (2002).
Castellino, F.J. et al. Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb. Haemost. 88, 462–472 (2002).
Oren, M. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274, 36031–36034 (1999).
Carr, A.M. Cell cycle. Piecing together the p53 puzzle. Science 287, 1765–1766 (2000).
Ogawara, Y. et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J. Biol. Chem. 277, 21843–21850 (2002).
Stempien-Otero, A. et al. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J. Biol. Chem. 274, 8039–8045 (1999).
Kimura, M. et al. Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J. Biol. Chem. 276, 26453–26460 (2001).
Zhu, Y. et al. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons. J. Biol. Chem. 277, 22909–22914 (2002).
Gale, A.J., Sun, X., Heeb, M.J. & Griffin, J.H. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Protein Sci. 6, 132–140 (1997).
Ye, X. et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochem. Biophys. Res. Commun. 259, 671–677 (1999).
Vaughan, P.J, Pike, C.J, Cotman, C.W & Cunningham, D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389–5401 (1995).
Striggow, F. et al. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl. Acad. Sci. USA 97, 2264–2269 (2000).
Turgeon, V.L. et al. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 6882–6891 (1998).
Donovan, F.M & Cunningham, D.D. Signaling pathways involved in thrombin-induced cell protection. J. Biol. Chem. 273, 12746–12752 (1998).
Miyashita, T. & Reed, J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293–299 (1995).
Yamamoto, K. et al. Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells. Hypertension 37, 1341–1348 (2001).
Faleiro, L. & Lazebnik, Y. Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 151, 951–959 (2000).
Ackermann, E.J., Taylor, J.K., Narayana, R. & Bennett, C.F. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274, 11245–11252 (1999).
Hoffmann, A., Gloe, T. & Pohl, U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell. Physiol. 188, 33–44 (2001).
Wang, Y.F. et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228–231 (1998).
Flavin, M.P., Zhao, G. & Ho, L.T. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29, 347–354 (2000).
Heeb, M.J et al. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb. Res. 52, 33–43 (1988).
Mackic, J.B. et al. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734–743 (1998).
Acknowledgements
This work was supported by US National Institutes of Health grant HL63290 and HL52246.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.V.Z. has a financial relationship with Socratech, LLC, relative to his service in the capacity of Scientific Program Director. He receives consultation compensation, stock ownership and other equity interest. The relationship includes patent applications and may include trademarks, copyrights and/or licensing agreements. J.H.G. has a financial relationship with Socratech, LLC, as a member of their Scientific Advisory Board, with similar compensations and inclusions.
Rights and permissions
About this article
Cite this article
Cheng, T., Liu, D., Griffin, J. et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9, 338–342 (2003). https://doi.org/10.1038/nm826
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm826
This article is cited by
-
Identification of a broad lipid repertoire associated to the endothelial cell protein C receptor (EPCR)
Scientific Reports (2022)
-
Lentiviral CRISPR-guided RNA library screening identified Adam17 as an upstream negative regulator of Procr in mammary epithelium
BMC Biotechnology (2021)
-
Long-term outcomes of intravitreal activated protein C injection for ischemic central retinal vein occlusion: an extension trial
Graefe's Archive for Clinical and Experimental Ophthalmology (2021)
-
PPARα activation directly upregulates thrombomodulin in the diabetic retina
Scientific Reports (2020)
-
Evaluation of 3K3A-Activated Protein C to Treat Neonatal Hypoxic Ischemic Brain Injury in the Spiny Mouse
Neurotherapeutics (2019)